Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-716-0
CAS number: 98-95-3
dose of 360 mg/kg did not cause mortalities, but all of the animals
demonstrated clinical signs. These clinical signs included cyanosis (all
dose groups), perturbance of equilibrium, piloerection, sedation 600 –
840 mg/kg bw), bloody eyes and poor reflexes. In animals receiving up to
480 mg/kg bw, clinical signs occurred 1 h after administration whereas
in all other dose groups they occurred alreade after 15 min. 2/10 rats
died after administration of 480 mg/kg, 5/10 rats after 600 mg/kg, 8/10
rats after 720 mg/kg and all 10 rats after 840 mg/kg. Mortalities
occurred on days 2 to 4. Information on necropsy is not given.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Sellel veebilehel kasutatakse küpsiseid, et tagada lehe parim kasutus.
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
Do not show this message again